InvestorsObserver is giving Cumberland Pharmaceuticals, Inc. (CPIX) an Analyst Rating Rank of 78, meaning CPIX is ranked higher by analysts than 78% of stocks. The average price target for CPIX is $8.5 and analyst’s rate the stock as a Strong Buy
Why are Analyst Ratings Important?
Analysts know the inner workings of the companies they follow better than anyone but the companies’ management. You can learn a lot about a company from studying the financial statements, but analysts ask questions on conference calls and understand the intricacies of each of the businesses they cover. Analysts understand how bad weather in one part of the world can disrupt supply chains, or disrupt shopping patterns. This lets traders make decisions before a quarterly report that could be worse than expected.
InvestorsObserver aggregates the ratings of all the analysts covering a given stock, takes the average of those ratings and then percentile ranks the averages. That provides a level of granularity that is significantly better than just the three levels provided by traditional buy/hold/sell ratings.
What's Happening With Cumberland Pharmaceuticals, Inc. Stock Today?
Cumberland Pharmaceuticals, Inc. (CPIX) stock has gained 1.82% while the S&P 500 is lower by -0.28% as of 2:00 PM on Thursday, Feb 11. CPIX has risen $0.06 from the previous closing price of $3.29 on volume of 149,367 shares. Over the past year the S&P 500 has gained 15.37% while CPIX is lower by -26.54%. CPIX lost -$0.22 per share the over the last 12 months.
Click Here to get the full report on Cumberland Pharmaceuticals, Inc. (CPIX) Stock.
